Cargando…

Aggressive multimodal therapy may prolong disease-free survival in recurrent primary retroperitoneal embryonal carcinoma

INTRODUCTION: Primary retroperitoneal extragonadal tumours relapsing after initial chemotherapy have a poor prognosis. PRESENTATION OF THE CASE: We report a case of primary retroperitoneal embryonal carcinoma in a patient with negative open testes biopsy. After the first line of chemotherapy (4 cycl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Straka, Martin, Manasek, Viktor, Stursa, Miroslav, Andelova, Romana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430178/ https://www.ncbi.nlm.nih.gov/pubmed/25799960 http://dx.doi.org/10.1016/j.ijscr.2015.03.018

Ejemplares similares

THE APPEARANCE OF GRANULES IN THE GOLGI COMPLEX OF EMBRYONIC CARDIAC MYOCYTES
por: Manasek, Francis J.
Publicado: (1969)

Factors associated with disease‐free and abdominal recurrence‐free survival in abdominopelvic and retroperitoneal sarcomas
por: Bredbeck, Brooke C., et al.
Publicado: (2022)

An Aggressive Retroperitoneal Fibromatosis
por: Campara, Zoran, et al.
Publicado: (2016)

Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma
por: Zhuang, Aobo, et al.
Publicado: (2021)

Metastatic insulinoma – prolonged survival after multimodal approach
por: Hagel, Alexander F., et al.
Publicado: (2011)

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
por: Hussain, Nasir, et al.
Publicado: (2013)

Recurrent Retroperitoneal Cystic Lymphangioma
por: Ozdemir, Huseyin, et al.
Publicado: (2005)

Management of Recurrent Retroperitoneal Sarcoma
por: Jolissaint, Joshua S., et al.
Publicado: (2023)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

MITOSIS IN DEVELOPING CARDIAC MUSCLE
por: Manasek, Francis J.
Publicado: (1968)

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer
por: Jiang, Donggen, et al.
Publicado: (2018)

Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
por: Zhao, Mingkun, et al.
Publicado: (2022)

Clinical analysis of 5-year survival and recurrence in giant retroperitoneal liposarcoma after surgery
por: Deng, Huan, et al.
Publicado: (2023)

Surgical Resection of Retroperitoneal Aggressive Angiomyxoma: Case Report and Review of the Literature
por: Beuran, Mircea, et al.
Publicado: (2017)

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
por: Feng, Long-Hai, et al.
Publicado: (2023)

Multimodal treatment of aggressive forms of breast cancer
por: Mihai, D, et al.
Publicado: (2014)

Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen–Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma
por: Xue, Guo-Qiang, et al.
Publicado: (2021)

Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma
por: Nathenson, Michael J, et al.
Publicado: (2018)

Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.
por: Hedley, D. W., et al.
Publicado: (1978)

Five-Year, Disease-Free Survival after Repeat Palliative Multimodality Therapy in a Patient with Recurrent Metastastic Bladder Cancer
por: Fetscher, Sebastian, et al.
Publicado: (2007)

Giant recurrent retroperitoneal liposarcoma presenting as a recurrent inguinal hernia
por: Bhandarwar, Ajay H., et al.
Publicado: (2011)

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
por: Nakano-Tateno, Tae, et al.
Publicado: (2021)

Radiation Therapy in Addition to Gross Total Resection of Retroperitoneal Sarcoma Results in Prolonged Survival: Results from a Single Institutional Study
por: Zagar, Timothy M., et al.
Publicado: (2008)

Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer
por: Gast, Marie-Christine W., et al.
Publicado: (2011)

APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC
por: Li, Yanping, et al.
Publicado: (2021)

Massive Retroperitoneal Hemorrhage as an Initial Presentation of a Rare and Aggressive Form of Multiple Myeloma
por: Alawadhi, Aydah, et al.
Publicado: (2016)

Aggressive surgical approach with vascular resection and reconstruction for retroperitoneal sarcomas: a systematic review
por: Hu, Hankui, et al.
Publicado: (2023)

The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma
por: Ashida, Ryo, et al.
Publicado: (2018)

Developmental eye motion plasticity after unilateral embryonic ear removal in Xenopus laevis
por: Gordy, Clayton, et al.
Publicado: (2022)

Multimodal imaging features of retroperitoneal anastomosing hemangioma: a case report and literature review
por: Zhang, Liqing, et al.
Publicado: (2023)

Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial
por: Hart, C., et al.
Publicado: (2015)

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
por: Ysermans, Renée, et al.
Publicado: (2022)

Retroperitoneal Approach for Recurrent Benign Multicystic Peritoneal Mesothelioma
por: Bakhshi, Girish D., et al.
Publicado: (2013)

Predictors and outcomes of recurrent retroperitoneal liposarcoma with multiple tumors
por: Deng, Huan, et al.
Publicado: (2023)

Embryonal Rhabdomyosarcoma with Posttherapy Cytodifferentiation and Aggressive Clinical Course
por: Jeyaraju, Maniraj, et al.
Publicado: (2021)

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
por: van Oers, Marinus, et al.
Publicado: (2019)

Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report
por: Sota, Yuki, et al.
Publicado: (2021)

Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report
por: Sota, Yuki, et al.
Publicado: (2021)

THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2023)

Multimodal transcriptional control of pattern formation in embryonic development
por: Lammers, Nicholas C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_htcjchvnseda6een2eef092ajd